Published in J Neurosci on December 01, 1996
Task-specific dystonias: a review. Ann N Y Acad Sci (2008) 1.54
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol (2007) 1.24
Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? Prog Neurobiol (2008) 1.19
Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology (2008) 0.92
Childhood onset generalised dystonia can be modelled by increased gain in the indirect basal ganglia pathway. J Neurol Neurosurg Psychiatry (2003) 0.84
Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease. Front Neurosci (2013) 0.83
Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease. Brain Behav (2013) 0.81
Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease. Neuroscience (2013) 0.81
Research Priorities in Limb and Task-Specific Dystonias. Front Neurol (2017) 0.78
Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain. Synapse (2016) 0.75
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes. Front Neurol (2015) 0.75
Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats. Neurosci Lett (2013) 0.75
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology (2001) 4.74
Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry (1991) 4.12
A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr (1985) 3.13
Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology (2011) 2.61
Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology (2011) 2.53
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology (2005) 2.41
Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations. J Cereb Blood Flow Metab (1987) 2.33
Standardized mean regional method for calculating global positron emission tomographic measurements. J Cereb Blood Flow Metab (1985) 2.21
Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem (1996) 2.17
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science (1994) 1.98
Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem (2001) 1.87
Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J Med Genet (1999) 1.86
Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology (2003) 1.66
Analysis of the structure and expression of the human dopamine D2A receptor gene. J Neurochem (1991) 1.64
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem (2000) 1.60
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci (1999) 1.58
Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol (2007) 1.53
Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology (1989) 1.51
Template images for nonhuman primate neuroimaging: 1. Baboon. Neuroimage (2001) 1.49
A simpler, less expensive technique for delayed primary closure of fasciotomies. Am J Surg (2000) 1.48
Regional asymmetries of cerebral blood flow, blood volume, and oxygen utilization and extraction in normal subjects. J Cereb Blood Flow Metab (1987) 1.48
Stimulation of STN impairs aspects of cognitive control in PD. Neurology (2004) 1.44
Novel THAP1 sequence variants in primary dystonia. Neurology (2010) 1.42
Technology assessment revisited: does positron emission tomography have proven clinical efficacy? Neurology (1991) 1.39
Template images for nonhuman primate neuroimaging: 2. Macaque. Neuroimage (2001) 1.35
Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci U S A (1992) 1.35
Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res (1999) 1.35
The effect of spinal immobilization on healthy volunteers. Ann Emerg Med (1994) 1.34
Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol (1990) 1.34
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience (2006) 1.22
Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain (2008) 1.22
Putamen volume in idiopathic focal dystonia. Neurology (1998) 1.17
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
Regional blood flow in hemiparkinsonism. Neurology (1985) 1.14
Abnormal cortical responses in patients with writer's cramp. Neurology (1993) 1.14
Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol (2000) 1.12
Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice. J Neurophysiol (1998) 1.12
Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue. Gut (1982) 1.12
Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. Mol Pharmacol (2001) 1.12
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
Effect of pre- and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res (1991) 1.07
An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem (1997) 1.07
Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J Pharmacol Exp Ther (1996) 1.06
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther (1994) 1.05
Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry (1987) 1.04
Translation of hepatitis A virus RNA in vitro: aberrant internal initiations influenced by 5' noncoding region. Virology (1991) 1.04
A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J Neurochem (2000) 1.04
Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J Comp Neurol (1996) 1.04
Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.03
Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia (2008) 1.03
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord (2005) 1.01
Pathophysiology of parkinsonism due to hydrocephalus. J Neurol Neurosurg Psychiatry (2004) 1.01
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99
Dopa-induced blood flow responses in nonhuman primates. Exp Neurol (2000) 0.99
Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia. Brain (1990) 0.99
Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children. Rev Infect Dis (1987) 0.98
Dopamine D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther (1994) 0.98
Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry (2001) 0.97
Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology (1998) 0.97
Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus (1999) 0.97
Expression of rat tyrosine hydroxylase in insect tissue culture cells and purification and characterization of the cloned enzyme. J Biol Chem (1990) 0.97
Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci (1998) 0.96
Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res Mol Brain Res (1990) 0.96
Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci (1993) 0.95
The behavioral complications of pallidal stimulation: a case report. Brain Cogn (2000) 0.95
Comparative analysis of the isoform expression pattern of Ca(2+)-regulatory membrane proteins in fast-twitch, slow-twitch, cardiac, neonatal and chronic low-frequency stimulated muscle fibers. Biochim Biophys Acta (2000) 0.94
Species and regional differences in the expression of cell-type specific elements at the human and rat tyrosine hydroxylase gene loci. J Neurochem (1990) 0.94
Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proc Natl Acad Sci U S A (1998) 0.94
The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol (1992) 0.93
Effects of the North Carolina Prematurity Prevention Program among public patients delivering at New Hanover Memorial Hospital. Am J Public Health (1988) 0.92
A normal spinal position: It's time to accept the evidence. J Manipulative Physiol Ther (2001) 0.92
Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis. Brain Res Mol Brain Res (1997) 0.91
Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol (2012) 0.91
In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding. J Cereb Blood Flow Metab (1997) 0.90
Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition. Mol Neurobiol (1998) 0.90
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology (2003) 0.90
Pure hemidystonia with basal ganglion abnormalities on positron emission tomography. Ann Neurol (1984) 0.90
Survival of Salmonella species in river water. Curr Microbiol (2000) 0.89
Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Exp Neurol (1999) 0.89
The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study. Acta Oncol (1991) 0.89
Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease. J Neurol Neurosurg Psychiatry (2011) 0.88
Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology (1992) 0.88
Regional correction of positron emission tomography data for the effects of cerebral atrophy. J Cereb Blood Flow Metab (1988) 0.88
Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates. Nucl Med Biol (1997) 0.88
L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease. Exp Neurol (1997) 0.88
Pediatric all-terrain vehicle trauma: a 5-year statewide experience. J Pediatr Surg (1998) 0.87
PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function. J Neurosci (1997) 0.87
Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties. J Neurosci (1995) 0.86
Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease. Exp Neurol (2012) 0.86
A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2). Nucleic Acids Res (1991) 0.85
kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons. J Neurosci (1999) 0.84
Dopamine D(1) agonist activates temporal lobe structures in primates. J Neurophysiol (2000) 0.84